NasdaqCM - Delayed Quote • USD
Pieris Pharmaceuticals, Inc. (PIRS)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:50 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | -- |
Avg. Estimate | -0.12 | 0 | -0.35 | 0 |
Low Estimate | -0.12 | 0 | -0.35 | 0 |
High Estimate | -0.12 | 0 | -0.35 | 0 |
Year Ago EPS | -8.8 | -14.4 | -36 | -0.35 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 1.3M | 2.24M | 42.81M | 6.62M |
Low Estimate | 2.24M | 2.24M | 31.98M | 6.62M |
High Estimate | 2.24M | 2.24M | 31.98M | 6.62M |
Year Ago Sales | 5.85M | 6.5M | 25.9M | 42.81M |
Sales Growth (year/est) | -77.80% | -65.50% | 65.30% | -84.50% |
Earnings History
CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
---|---|---|---|---|
EPS Est. | -18.4 | -11.2 | -12.8 | -8.8 |
EPS Actual | -8.8 | -14.4 | 4 | 3.2 |
Difference | 9.6 | -3.2 | 16.8 | 12 |
Surprise % | 52.20% | -28.60% | 131.20% | 136.40% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Current Estimate | -0.12 | 0 | -0.35 | 0 |
7 Days Ago | -0.12 | -0.06 | -0.35 | -0.2 |
30 Days Ago | -0.12 | -0.06 | -0.35 | -0.2 |
60 Days Ago | -0.12 | -0.06 | -0.35 | -0.2 |
90 Days Ago | -0.12 | -0.06 | -0.35 | -0.2 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | PIRS | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 98.60% | -- | -- | 5.40% |
Next Qtr. | -- | -- | -- | 10.90% |
Current Year | 99.00% | -- | -- | 4.50% |
Next Year | -- | -- | -- | 13.10% |
Next 5 Years (per annum) | -- | -- | -- | 10.94% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Upgrade | Baird: Neutral to Outperform | 3/13/2020 |
Downgrade | Baird: Outperform to Neutral | 7/30/2019 |
Initiated | Baird: Outperform | 5/14/2019 |
Initiated | Cowen & Co.: Outperform | 5/4/2018 |
Initiated | Evercore ISI Group: Outperform | 3/19/2018 |
Initiated | Jefferies: Buy | 3/19/2018 |
Related Tickers
BPTS Biophytis S.A.
8.22
0.00%
WINT Windtree Therapeutics, Inc.
5.23
+2.55%
GRTX Galera Therapeutics, Inc.
0.1861
-10.31%
ATXI Avenue Therapeutics, Inc.
6.20
-29.35%
ZVSA ZyVersa Therapeutics, Inc.
4.9900
-16.83%
AFMD Affimed N.V.
5.03
+3.07%
LPTX Leap Therapeutics, Inc.
3.2500
+2.52%
PHIO Phio Pharmaceuticals Corp.
0.6820
+1.34%
CTMX CytomX Therapeutics, Inc.
1.5900
-0.62%
CDTX Cidara Therapeutics, Inc.
12.63
-2.85%